title: Invited commentary.
authors.affiliation: Department of Cardiothoracic Surgery, General Hospital Vienna, Meduniwien, Währinger Gürtel 18-20, Vienna, A-1090 Austria.
authors.forename: Hendrik Jan
authors.initials: HJ
authors.lastname: Ankersmit
authors.forename: Bernhard
authors.initials: B
authors.lastname: Moser
authors.forename: Ernst
authors.initials: E
authors.lastname: Wolner
mesh_terms: D004198:Disease Susceptibility; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006680:HLA Antigens / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology; D006353:Heart-Assist Devices / Q000009:adverse effects; D006801:Humans; D007114:Immunization; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007239:Infections / Q000209:etiology; D011673:Pulsatile Flow; D012189:Retrospective Studies; D017211:Treatment Failure
chemical_list: D006680:HLA Antigens; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D007166:Immunosuppressive Agents